A pilot study evaluating the impact of ibudilast on prevention of chemotherapy-induced neurotoxicity and evaluating pharmacokinetics in metastatic gastro-intestinal cancer patients receiving oxaliplatin
Phase of Trial: Phase I
Latest Information Update: 03 Sep 2018
At a glance
- Drugs Ibudilast (Primary) ; Capecitabine; Fluorouracil; Oxaliplatin
- Indications Chemotherapy-induced damage; Peripheral neuropathies
- Focus Therapeutic Use
- 29 Aug 2018 Status changed from planning to recruiting.
- 04 Apr 2018 New trial record
- 28 Mar 2018 According to a MediciNova media release, a Concord Cancer Centre Research grant will provide funding for this study and MediciNova will provide study drug.